InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,468.00
(
0.28%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.58
(
0.55%
)
Bitcoin
64,127.04
(
0.20%
)
Post# of 36211
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Groveman1

Send PM Follow Ignore
Followers 14
Posts 2221
Boards Moderated 0
Alias Born 02/27/2015

Groveman1

Re: None

Monday, 08/14/2017 8:44:20 PM

Monday, August 14, 2017 8:44:20 PM

Post# of 36211
Not for nothing, has anyone been wondering what is going on with these trials. They should be completed already, no matter how tough to find patients.There are millions of women who could use this product and a trial on under 200 patients cannot be completed. Seems odd. Holding and waiting with 10 mill. since 2009.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!